Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains.

Authors
Type
Published Article
Journal
The Journal of rheumatology
Publication Date
Volume
39
Issue
6
Pages
1130–1138
Identifiers
DOI: 10.3899/jrheum.111513
PMID: 22505705
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments